ArticleBone marrow transplantation2025

Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT.

Jaime Sanz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.